1. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Crispino, F.; Grova, M.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Ferracane, C.; Belluardo, N.; Giangreco, E.; Fries, W.; Viola, A.; Di Mitri, R.; Mocciaro, F.; Camilleri, S.; Garufi, S.; Renna, S.; Casà, A.; Maida, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Busacca, A.; Fries, W.; Viola, A.; Costantino, G.; Magnano, A.; Vinci, E.; Ferracane, C.; Privitera, A.C.; Piccillo, G.; Belluardo, N.; Giangreco, E.; Romano, C.; Citrano, M.; Graziano, F.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Scrivo, B. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.02.2 NEW ORAL ANTICOAGULANTS (NOACS) INCREASE THE RISK FOR ANEMIA AND HOSPITALIZATIONS IN IBD PATIENTS. (1st October 2020) Authors: Abbruzzese, A.; Viola, A.; Scolaro, M.; Costantino, G.; Mandraffino, G.; Versace, A.; Alibrandi, A.; Fries, W. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC.02.3 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). (1st October 2020) Authors: Macaluso, F.S.; Ventimiglia, M.; Fries, W.; Viola, A.; Cappello, M.; Scrivo, B.; Magnano, A.; Pluchino, D.; Camilleri, S.; Garufi, S.; Di Mitri, R.; Mocciaro, F.; Magrì, G.; Ferracane, C.; Citrano, M.; Graziano, F.; Bertolami, C.; Renna, S.; Orlando, R.; Rizzuto, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.02.5 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART1. Issue 2 (15th March 2018) Authors: Bergamaschi, G.; Giuffrida, P.; Fries, W.; Aronico, N.; D'Incà, R.; Lenti, M.V.; Ciacci, C.; Cococcia, S.; Bossa, F.; Ghigliazza, G.; Castiglione, F.; Principi, M.B.; Ricci, C.; Mazzucco, D.; Milla, M.; Pieraccini, A.; Scribano, M.L.; Riegler, G.; Bodini, G.; Bassotti, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety. (15th March 2017) Authors: Orlando, A.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, A.; Carroccio, A.; Genova, S.; Calandruccio, G.; Vassallo, R.; Romano, C.; Magazzù, G.; Citrano, M.; Accomando, S. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.09.6 PERFORATING CROHN'S DISEASE AND EXTENSIVE COLITIS AS RISK FACTORS FOR INCIDENT CANCER: A MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY AT 6 YEARS. (25th March 2019) Authors: Petruzziello, C.; Armuzzi, A.; Scribano, M.L.; Castiglione, F.; D'Incà, R.; Daperno, M.; Papi, C.; Vecchi, M.; Fries, W.; Riegler, G.; Alvisi, P.; Mocciaro, F.; Testa, A.; Festa, S.; Neri, B.; Calabrese, E.; De Cristofaro, E.; Gesuale, C.; Di Mitri, R.; Spina, L. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE. (May 2022) Authors: Macaluso, F.S.; Grova, M.; Saladino, M.; Demarzo, M.G.; Privitera, A.C.; Giangreco, E.; Garufi, S.; Renna, S.; Casà, A.; Ventimiglia, M.; Cappello, M.; Fries, W.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.10.5 EARLY DIAGNOSIS IN INFLAMMATORY BOWEL DISEASE (IBD) – A PILOT STUDY. Issue 2 (15th March 2018) Authors: Fries, W.; Belvedere, A.; Alecci, U.; Alibrandi, A.; Bruno, L.M.; Crescenti, A.; Di Geronimo, L.; Inferrera, S.; Marino, S.; Scoglio, R. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.11.1 INFLAMMATORY BOWEL DISEASE PHENOTYPE AS RISK FACTOR FOR CANCER IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY. (24th February 2016) Authors: Biancone, L.; Armuzzi, A.; Scribano, M.L.; D'Incà, R.; Castiglione, F.; Papi, C.; Angelucci, E.; Daperno, M.; Riegler, G.; Fries, W.; Meucci, G.; Alvisi, P.; Spina, L.; Ardizzone, S.; Petruzziello, C.; Mocciaro, F.; Ruffa, A.; Kohn, A.; Vecchi, M.; Guidi, L. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗